Respiratory distress syndrome: the preventive use of glucocorticoids.
D000650:Amnion / Q000473:pathology; D000818:Animals; D001623:Betamethasone / Q000627:therapeutic use; D005260:Female; D005333:Fetus / Q000503:physiopathology; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006819:Hyaline Membrane Disease / Q000209:etiology / Q000503:physiopathology; D006973:Hypertension / Q000209:etiology; D007231:Infant, Newborn; D008168:Lung / Q000002:abnormalities / Q000254:growth & development / Q000503:physiopathology; D007862:Phosphatidylcholine-Sterol O-Acyltransferase / Q000502:physiology; D011247:Pregnancy; D011248:Pregnancy Complications / Q000503:physiopathology; D011663:Pulmonary Surfactants / Q000009:adverse effects / Q000502:physiology; D012127:Respiratory Distress Syndrome, Newborn / Q000517:prevention & control*; D013109:Sphingomyelins / Q000502:physiology
D005938:Glucocorticoids; D011663:Pulmonary Surfactants; D013109:Sphingomyelins; D001623:Betamethasone; D007862:Phosphatidylcholine-Sterol O-Acyltransferase